Pulsus invites you to attend ‘International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders’ that is to be held during 4-5 December 2017 at Madrid, Spain providing an international platform for physicians, rheumatologists, young researchers, students, physiatrists, orthopedists, and geriatricians to share the information and scientific progress in treating osteoporosis and musculoskeletal disorders.

This conference concentrates on the newest and advanced innovations in all the areas of osteoporosis and arthritis research. This conference highlights the theme, ‘Osteoporosis and Musculoskeletal Disorders as primary health concern’ that emphasises on quality health of the world population. The conference includes workshops, symposiums, special keynote sessions conducted by eminent and notable speakers who surpass in the field of orthopaedics that include the topics osteoporosis, osteoarthritis, rheumatoid arthritis, musculoskeletal disorders, prevalence and risk factors, pharmacological treatment, alternative treatments, nutrition and prevention. This international conference additionally encourages the active participation of young student researchers since we are hosting Poster Award Competition and Young research Forum at the conference venue.

Why to attend:

Medical doctors, patients and healthcare providers contemplate the hindrance of orthopaedic diseases as a vital tool to enhance the overall health status of the population. Worldwide, osteoporosis causes over 8.9 million fractures annually, leading to an osteoporotic fracture every three seconds. Musculoskeletal conditions have a significant impact on society due to their incidence, severity, and resultant incapacity.

Osteoporosis is estimated to have an effect on two hundred million women worldwide – about ten percent of women aged sixty, twenty percent of women aged seventy, forty percent of women aged eighty and thirty three percent of women aged ninety. It is estimated that the residual lifetime risk of experiencing an osteoporotic fracture in men over the age of fifty is up to twenty seven. Osteoarthritis is irreversible, thereby difficult to cure. The genetic contribution to susceptibility of rheumatoid arthritis is estimated to be 60%. Recognising the importance of this issue, Pulsus group is set to arrange a conference on osteoporosis and musculoskeletal disorders during 4-5 December 2017 at Madrid, Spain planning to increase awareness of the diseases with relation to current standing and future burden of the diseases on world population. This conference additionally provides a worldwide platform for physicians, rheumatologists, young researchers, students, physiatrists, orthopedists, and geriatricians to share the information and scientific progress in treatments.